-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q2 2023.
- Eagle Pharmaceuticals, Inc. Costs and Expenses for the quarter ending June 30, 2023 was $54.3M, a 24.5% decline year-over-year.
- Eagle Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending June 30, 2023 was $217M, a 0.99% increase year-over-year.
- Eagle Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $236M, a 39.6% increase from 2021.
- Eagle Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $169M, a 9% increase from 2020.
- Eagle Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $155M, a 11% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)